ECCO'24 Abstracts

ECCO'24 Abstracts on the JCC Website

ECCO'24 Abstract Book PDF Version

ECCO'24 Abstracts COI Disclosure

Poster presentations: Epidemiology 2020

P740 Age determines the risk of familial IBD: A nationwide case–control study

P741 Incidence and clinical phenotype of inflammatory bowel disease in the north–west of Spain (Vigo) between 1991 and 2011

P742 Morbidity and mortality outcomes of paediatric-onset inflammatory bowel disease in early adult life: A Scottish population-based, nested case–control study

P743 Time trends of Crohn’s disease in Catalonia from 2011 to 2017. Increasing use of biologics correlates with a reduced need for surgery. A population-based study in Catalonia

P744 Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): Results from the nationwide EpidemIBD study of GETECCU

P745 Perianal disease in Crohn’s disease is associated with higher rate of hospitalisation and mortality despite a higher utilisation of biologics: Report from the epiIIRN cohort

P746 Prevalence, features and outcomes of splachnic vein thrombosis in inflammatory bowel disease. A nationwide, retrospective study from the ENEIDA registry

P747 Adherence to ECCO guidelines for cancer surveillance is associated to the detection of early cancer: A retrospective, single-centre, cohort study

P748 Characteristics of inflammatory bowel diseases in different stage of adolescence

P749 Epidemiological and clinical characterisation of inflammatory bowel disease (IBD) in Latin America and the Caribbean: The EPI-LATAM IBD study from the Pan American Crohn’s colitis organisation

P750 Prevalence and characteristics of incidentally diagnosed inflammatory bowel disease during screening colonoscopy

P751 Prevalence and risk factors of non-alcoholic fatty liver disease in inflammatory bowel diseases

P752 A nationwide survey of chronic enteropathy associated with SLCO2A1 gene in Japan

P753 Elevation of liver enzymes in a large cohort of patients with inflammatory bowel disease

P754 Inflammatory bowel disease-like disease in patients with primary immunodeficiencies with chronic digestive symptoms: Diagnostic yield of colonoscopy

P755 Congenital chloride diarrhoea and inflammatory bowel disease: an emerging association

P756 Cervical smear screening results amongst women with inflammatory bowel disease at an Irish hospital

P757 Focusing on the future: Reducing barriers and improving access to inflammatory bowel disease specialty care across Canada

P758 Ileorectal anastomosis vs. ileal pouch-anal anastomosis for the surgical treatment of ulcerative colitis: A Markov decision analysis

P759 Correlation of quality-of-life components with sexual function scores and disease duration in patients with inflammatory bowel disease

P760 Differences in persistence of oral mesalazine preparations as monotherapy in patients with ulcerative colitis

P761 Illness cognition of Saudi patients with Crohn’s disease

P762 Prevalence association between HPV and fistulising perianal Crohn’s disease

P763 Epstein–Barr virus serological status in paediatric patients with inflammatory bowel disease

P764 Phenotypic analysis of patients with inflammatory bowel disease: 23 year data of a centre in a South American country

P765 Fatigue as one of the most important symptoms in adult patients with inflammatory bowel disease: Croatian tertiary centre pilot study

P766 ABO blood groups and ulcerative colitis: A hospital-based study in central Taiwan

P767 Prevalence and incidence rates of inflammatory bowel disease among First Nations: Population-based evidence from Saskatchewan, Canada

P768 Long-term prognosis of Crohn’s disease and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea

P769 Prevalence and duration of gastrointestinal symptoms in the 10 years before diagnosis of inflammatory bowel disease: A national cohort study

P770 Ascertainment of pediatric inflammatory bowel disease cases from administrative health data in Québec, Canada

P771 Increasing prevalence and direct health care cost of inflammatory bowel disease: A population-based evidence from a western Canadian province

P772 Trends and risk factors of elderly-onset Crohn’s disease: A nationwide cohort study in South Korea

P773 Patient reported outcomes, partial MAYO score and SCCAI are equally accurate in predicting mucosal healing in UC: Preliminary results from a prospective study

P774 Low adhesion to latent tuberculosis (TB) screening recommendations in inflammatory bowel disease (IBD) patients: Results of the INFEII registry of GETECCU

P775 Evolution of inflammatory bowel disease research from a bird’s eye perspective: A text-mining analysis of publication trends and topics

P776 Hospital re-admission in patients with inflammatory bowel disease: what are the risk factors?

P777 Clostridioides difficile infection in children with inflammatory bowel disease: A Canadian population-based study

P778 Longitudinal trajectory of fatigue in inflammatory bowel disease patients: a prospective study

P779 Intestinal cancer associated with Crohn’s disease: difference between those with short duration and those with long duration

P780 Proteinuria is associated with the development of Crohn’s disease: a nationwide population-based study

P781 Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy

P782 Immune status to viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases

P783 Non-alcoholic fatty liver disease and advanced liver disease in patients with inflammatory bowel disease: prevalence and risk factors

P784 A new questionnaire to investigate patients’ knowledge of relevant aspects of inflammatory bowel disease clinical course and outcomes: preliminary results

P785 Predictors of mortality in IBD patients treated for pneumonia

P786 Non-alcoholic fatty liver disease among patients with inflammatory bowel disease in Qatar: Prevalence and risk factors

P787 Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicentre study

P788 Gender differences in consumption of processed and ultra-processed foods in Crohn’s disease patients

P789 Bacteriological profile of material collected from perianal lesions from patients with Crohn’s disease in the tertiary IBD centre in southern Poland

P790 Dental caries occurrence among patients with inflammatory bowel disease (IBD)

P791 Difference between paediatric Crohn’s disease and ulcerative colitis at diagnosis in Korea: results from a multicentre, registry-based, retrospective cohort study

P792 Breastfeeding in our patients with inflammatory bowel disease

P793 Patients’ concerns are strongly associated with distress and quality of life among family caregivers of adult inflammatory bowel disease patients in remission

P794 Nutritional assessment in inflammatory bowel disease (IBD): development of the Groningen IBD Nutritional Questionnaires (GINQ)

P795 Risk of incident paradoxical immune-mediated inflammatory diseases in patients with inflammatory bowel diseases treated with anti-TNF therapies: a nationwide Danish cohort study

P796 Annual prevalence and clinical outcomes of ulcerative colitis with primary sclerosing cholangitis in Korea over the last 10 years

P797 The inexorable increase of biological exposure in paediatric inflammatory bowel disease: a Scottish population-based, longitudinal study 2015–2019

P798 Societal costs attributable to Crohn’s disease and ulcerative colitis within the first 5 years after diagnosis: –a Danish Nationwide Cost-of-Illness Study 2003–2015

P799 Use of anti-TNF agents may reduce a risk of venous thromboembolism in Korean patients with inflammatory bowel disease: A nationwide population-based study from the National Health Insurance Database

P800 Treatment patterns for biologics in ulcerative colitis and Crohn’s disease: A Danish Nationwide Register Study from 2003 to 2015

P801 Treatment patterns of complex perianal fistula in Crohn’s disease in five European countries: the PREFACE study, a retrospective chart review

P802 Probability of vedolizumab response as defined by clinical decision support tool is associated with lower healthcare utilisation in patients with Crohn’s disease

P803 The risk of spine and hip fracture in patients with inflammatory bowel diseases: a nationwide population-based study

P804 Temporal trends and the influence of regional and socioeconomic status on the incidence of inflammatory bowel disease: Using National Health Insurance Service Database in Korea, 2005–2017

P805 Patients with Crohn’s disease treated with ustekinumab vs. vedolizumab in real-world settings

P806 Increasing incidence of microscopic colitis in a population-based cohort study in a French speaking region of Switzerland

P807 UCEIS is associated with PRO2, partial Mayo and SCCAI remission in UC: preliminary results from a prospective study

P808 Prevalence and factors associated with sleep disturbances in inflammatory bowel disease patients compared with normal controls

P809 Increase of tuberculosis due to combination therapy in inflammatory bowel disease: a nationwide population-based study in Korea

P810 Geriatric impairments in older inflammatory bowel disease patients are associated with higher disease burden: results of a multicentre cohort study

P811 A watchful approach for newly diagnosed Crohn’s disease patients with an inflammatory phenotype

P812 Inflammatory bowel disease and hepatopathies: Beyond primary sclerosing cholangitis

P813 Inflammatory bowel disease in older patients: experience at a single centre

P814 Incidence and significance of fatigue in patients with IBD

P815 Are hospitalised patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 2-year cohort study

P816 Association of autoimmune rheumatic disease with inflammatory bowel disease: a nationwide population-based study

P817 Influence of inflammatory bowel diseases on depression and suicidal risk: a questionnaire-based survey

P818 Venous thromboembolism is rare among hospitalised patients with an inflammatory bowel disease flare: a multicentre retrospective cross-sectional study

P819 Seroprevalence of Borrelia burgdorferi antibodies in patients with ulcerative colitis